💊

Prescription Drugs

💊 Drugs 11,927 recalls

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Dec 20, 2018 Prescription Drugs Nationwide View Details →

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Jan 30, 2019 Prescription Drugs Nationwide View Details →